Literature DB >> 1601420

Missense mutations and the magnitude of functional deficit: the example of factor IX.

S S Sommer1, E J Bowie, R P Ketterling, C D Bottema.   

Abstract

Some missense changes are compatible with normal protein function while others compromise essential aspects of protein maturation, specific activity, or stability. For those missense changes that alter function in the intact organism, how likely is it for the mutated protein to retain appreciable residual activity? By genetic analysis of patients with hemophilia B of known severity, this question can be addressed for missense mutations that reduce factor IX activity by fourfold or more below the average. We estimate that missense changes cause only 59% of moderate and severe disease, but these mutations are almost always (95%) of independent origin. In contrast, missense mutations are found in virtually all (97%) families with mild disease, but only a minority of these (41%) are of independent origin. From the aggregate data, we estimate that most (71%) of the independent deleterious missense mutations cause at least a 20-fold decrease in factor IX activity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1601420     DOI: 10.1007/bf00220543

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  11 in total

1.  Evidence that descendants of three founders constitute about 25% of hemophilia B in the United States.

Authors:  R P Ketterling; C D Bottema; J A Phillips; S S Sommer
Journal:  Genomics       Date:  1991-08       Impact factor: 5.736

2.  Haemophilia B: database of point mutations and short additions and deletions.

Authors:  F Giannelli; P M Green; K A High; J N Lozier; D P Lillicrap; M Ludwig; K Olek; P H Reitsma; M Goossens; A Yoshioka
Journal:  Nucleic Acids Res       Date:  1990-07-25       Impact factor: 16.971

3.  Missense mutations and evolutionary conservation of amino acids: evidence that many of the amino acids in factor IX function as "spacer" elements.

Authors:  C D Bottema; R P Ketterling; S Ii; H S Yoon; J A Phillips; S S Sommer
Journal:  Am J Hum Genet       Date:  1991-10       Impact factor: 11.025

4.  Current status of Swedish hemophiliacs. I. A demographic survey.

Authors:  S A Larsson; I M Nilsson; M Blombäck
Journal:  Acta Med Scand       Date:  1982

5.  Assay of factor IX antigen using an enzyme immuno assay.

Authors:  A Parquet-Gernez; C Mazurier; J Amiral; J L Martinoli
Journal:  Thromb Res       Date:  1984-09-15       Impact factor: 3.944

6.  Why does the human factor IX gene have a G + C content of 40%?

Authors:  C D Bottema; M J Bottema; R P Ketterling; H S Yoon; R L Janco; J A Phillips; S S Sommer
Journal:  Am J Hum Genet       Date:  1991-10       Impact factor: 11.025

7.  T296----M, a common mutation causing mild hemophilia B in the Amish and others: founder effect, variability in factor IX activity assays, and rapid carrier detection.

Authors:  R P Ketterling; C D Bottema; D D Koeberl; S Ii; S S Sommer
Journal:  Hum Genet       Date:  1991-07       Impact factor: 4.132

8.  The Pennsylvania hemophilia program 1973-1978.

Authors:  M E Eyster; J H Lewis; S S Shapiro; F Gill; M Kajani; D Prager; I Djerassi; S Rice; C Lusch; A Keller
Journal:  Am J Hematol       Date:  1980       Impact factor: 10.047

9.  A past mutation at isoleucine 397 is now a common cause of moderate/mild haemophilia B.

Authors:  C D Bottema; D D Koeberl; R P Ketterling; E J Bowie; S A Taylor; D Lillicrap; A Shapiro; G Gilchrist; S S Sommer
Journal:  Br J Haematol       Date:  1990-06       Impact factor: 6.998

10.  Genetic variants of hemophilia B: detection by means of a specific PTC inhibitor.

Authors:  H R Roberts; J E Grizzle; W D McLester; G D Penick
Journal:  J Clin Invest       Date:  1968-02       Impact factor: 14.808

View more
  6 in total

1.  Determinants of the factor IX mutational spectrum in haemophilia B: an analysis of missense mutations using a multi-domain molecular model of the activated protein.

Authors:  A I Wacey; M Krawczak; V V Kakkar; D N Cooper
Journal:  Hum Genet       Date:  1994-12       Impact factor: 4.132

2.  Germ-line origins of mutation in families with hemophilia B: the sex ratio varies with the type of mutation.

Authors:  R P Ketterling; E Vielhaber; C D Bottema; D J Schaid; M P Cohen; C L Sexauer; S S Sommer
Journal:  Am J Hum Genet       Date:  1993-01       Impact factor: 11.025

3.  The pattern of spontaneous germ-line mutation: relative rates of mutation at or near CpG dinucleotides in the factor IX gene.

Authors:  C D Bottema; R P Ketterling; E Vielhaber; H S Yoon; B Gostout; D P Jacobson; A Shapiro; S S Sommer
Journal:  Hum Genet       Date:  1993-06       Impact factor: 4.132

Review 4.  Diagnosis and care of patients with mild haemophilia: practical recommendations for clinical management.

Authors:  Gary Benson; Günter Auerswald; Gerry Dolan; Anne Duffy; Cedric Hermans; Rolf Ljung; Massimo Morfini; Silva Zupančić Šalek
Journal:  Blood Transfus       Date:  2017-11-14       Impact factor: 3.443

5.  A novel TMPRSS3 missense mutation in a DFNB8/10 family prevents proteolytic activation of the protein.

Authors:  Marie Wattenhofer; Nilüfer Sahin-Calapoglu; Ditte Andreasen; Ersan Kalay; Refik Caylan; Bastien Braillard; Nicole Fowler-Jaeger; Alexandre Reymond; Bernard C Rossier; Ahmet Karaguzel; Stylianos E Antonarakis
Journal:  Hum Genet       Date:  2005-07-14       Impact factor: 4.132

6.  The rates and patterns of deletions in the human factor IX gene.

Authors:  R P Ketterling; E L Vielhaber; T J Lind; E C Thorland; S S Sommer
Journal:  Am J Hum Genet       Date:  1994-02       Impact factor: 11.025

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.